Skip to main content
MDLN
NASDAQ Industrial Applications And Services

Major 10% Owner Sells $1.23 Billion in Medline Stock Following Secondary Offering

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Medical Instrument Stocks · Healthcare
Sentiment info
Negative
Importance info
8
Price
$35.51
Mkt Cap
$30.23B
52W Low
$34.34
52W High
$50.876
52W Position info
3.4% above low
Off High info
30% below high
Rel. Volume info
1.5× avg
Market data snapshot near publication time

MDLN is trading near its 52-week low of $34.34 (3.4% above the low).

Summary

A major 10% owner, Hellman & Friedman Capital Partners X, disposed of $1.23 billion of Medline stock, including $1.16 billion in open market sales, reducing their stake by 35% as part of a recent secondary offering.


Key Events · Ownership and Investor Activity · MDLN

  • Significant Share Disposition

    Hellman & Friedman Capital Partners X and related entities, a 10% owner, disposed of shares totaling $1,231,421,523.

  • Open Market Sales and Distributions

    This total includes $1,164,385,709 from open market sales (31,868,237 shares at $36.54) and 1,887,801 shares distributed in-kind to partners.

  • Part of Secondary Offering

    These transactions were executed on May 28, 2026, following the secondary offering priced on May 22, 2026.

  • Substantial Stake Reduction

    The disposition represents approximately 4.07% of Medline's market capitalization and a 35% reduction in the reporting entities' total holdings.


Analysis · MDLN · Industrial Applications And Services

Hellman & Friedman Capital Partners X and related entities, a significant 10% owner, have disposed of over $1.23 billion worth of Medline Class A Common Stock. This total disposition includes $1.16 billion from open market sales and additional shares distributed in-kind to their partners. Representing approximately 4.07% of the company's market capitalization and a 35% reduction in their prior holdings, this action is part of the secondary offering that was priced on May 22, 2026. The open market sales occurred at $36.54 per share, slightly below the $37.00 offering price due to underwriting discounts. This substantial reduction in stake by a major financial investor, especially while the stock is trading near its 52-week low, could be interpreted as a significant move to rebalance their portfolio or a reduced conviction.

How filings like this one have moved

In the 30 days to Sep 22, 2026, 34.8% of the 1044 measured filings Wiseek scored 8 moved their stock by 5% or more by the next session's close. The median move was -0.43%. These are measured outcomes after filings of this importance, not a forecast for this one.

Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset

At the time of this filing, MDLN was trading at $35.51 on NASDAQ in the Industrial Applications And Services sector, with a market capitalization of approximately $30.2B. The 52-week trading range was $34.34 to $50.88. This filing was assessed with negative market sentiment and an importance score of 8 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

MDLN - Latest Insights

MDLN
Aug 13, 2026, 2:00 PM EDT
Source: Benzinga
Importance Score:
7
Price at Filing: $36.08
Real-time Price: $33.60 info
Change: -$2.48 (-7%) info
Market Cap: $45.265B info
MDLN
Aug 05, 2026, 7:42 AM EDT
Source: Reuters
Importance Score:
8
Price at Filing: $38.00
Real-time Price: $33.60 info
Change: -$4.40 (-12%) info
Market Cap: $45.265B info
MDLN
Aug 05, 2026, 7:34 AM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $38.00
Real-time Price: $33.60 info
Change: -$4.40 (-12%) info
Market Cap: $45.265B info
MDLN
Jul 09, 2026, 4:00 PM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $40.85
Real-time Price: $33.60 info
Change: -$7.25 (-18%) info
Market Cap: $45.265B info
MDLN
Jul 08, 2026, 3:29 PM EDT
Source: Reuters
Importance Score:
7
Price at Filing: $40.51
Real-time Price: $33.60 info
Change: -$6.91 (-17%) info
Market Cap: $45.265B info